Clinical trial of tropomyosin inhibitor in children with neuroblastoma in the USA.

Trial Profile

Clinical trial of tropomyosin inhibitor in children with neuroblastoma in the USA.

Planning
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 20 May 2014

At a glance

  • Drugs Tropomyosin inhibitors (Primary)
  • Indications Neuroblastoma
  • Focus Adverse reactions
  • Sponsors Novogen
  • Most Recent Events

    • 20 May 2014 This trial is expected to start in 2015, according to a Novogen media release.
    • 20 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top